PGIM Private Credit Fund has announced a significant increase in its loan facility, raising the amount from $200 million to $300 million. This change, effective November 12, 2026, is part of an amendment to its Loan Financing and Servicing Agreement with Deutsche Bank AG and State Street Bank and Trust Company. The move is crucial for the fund as it enhances its financial flexibility and supports its growth strategy in the competitive private credit market.
Background
PGIM Private Credit Fund, a subsidiary of PGIM, operates within the private credit sector, focusing on providing financing solutions to various borrowers. The fund is incorporated in Delaware and is categorized as an emerging growth company. Its recent filings indicate ongoing activity in the capital markets, reflecting its active engagement in financing and investment opportunities.
What the Filing Says
The SEC filing reveals that on November 12, 2026, PGIM Private Credit Fund ABL LLC, a wholly owned subsidiary, entered into Amendment No. 2 to the Loan Financing and Servicing Agreement. This amendment not only increases the facility amount to $300 million but also adjusts the applicable margin. The filing states, "Among other changes, the Amendment: (i) increased the facility amount from $200 million to $300 million, and (ii) amended the applicable margin." This adjustment is expected to provide the fund with enhanced liquidity and operational capacity.
Impact
This increase in the loan facility may significantly affect various stakeholders, including the fund's investors, borrowers, and competitors in the private credit industry. By securing additional funding, PGIM Private Credit Fund positions itself to better meet the demands of its borrowers and expand its lending activities. Competitors may need to reassess their financing strategies in light of this development.
What's Next
The filing does not say what happens next, but the increased facility suggests that PGIM Private Credit Fund is preparing for future opportunities in the lending market. Investors and market analysts will be watching closely to see how this change impacts the fund's performance and its competitive positioning within the private credit sector.
Read Next
Q/C Technologies Enters Omnibus Amendment Agreement
ONE Nuclear Energy settles consulting fees with stock issuance
HCW Biologics delays stockholder vote amid quorum issues
bioAffinity Technologies amends share structure in 8-K filing
VisionWave amends sponsorship deal with Hen Basketball Haifa Club
Apimeds Pharmaceuticals Amends Agreement with FreeT Inc.










